U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492264) titled 'Evaluation of Food Supplementation in Subjects With Suboptimal Levels of LDL Cholesterol' on March 10.
Brief Summary: This randomized, double-blind, placebo-controlled, parallel-group clinical study aims to evaluate the effect of a dietary supplement on LDL-cholesterol levels in healthy adults with suboptimal LDL-C values. Eligible participants will follow standard dietary recommendations based on the Mediterranean diet, according to the European Atherosclerosis Society guidelines. Subjects will be randomized to receive either the dietary supplement (1 tablet/day) or placebo (1 tablet/day), both in combination with dietary recommen...